102 related articles for article (PubMed ID: 15984904)
1. Is the effect of antihypertensive drugs on platelet aggregability and fibrinolysis clinically relevant?
Fogari R; Zoppi A
Am J Cardiovasc Drugs; 2005; 5(4):211-23. PubMed ID: 15984904
[TBL] [Abstract][Full Text] [Related]
2. Antihypertensive drugs and fibrinolytic function.
Fogari R; Zoppi A
Am J Hypertens; 2006 Dec; 19(12):1293-9. PubMed ID: 17161777
[TBL] [Abstract][Full Text] [Related]
3. Antihypertensive drug treatment and fibrinolytic function.
Lottermoser K; Weisser B; Hertfelder HJ; Wöstmann B; Vetter H; Düsing R
Am J Hypertens; 1998 Mar; 11(3 Pt 1):378-84. PubMed ID: 9544880
[TBL] [Abstract][Full Text] [Related]
4. Effects of lisinopril, irbesartan, and amlodipine on the thrombogenic variables in the early and late stages of the treatment in hypertensive patients.
Tiryaki O; Usalan C; Buyukhatipoglu H; Sayiner ZA; Kilisli H
Clin Exp Hypertens; 2012; 34(2):145-52. PubMed ID: 21967026
[TBL] [Abstract][Full Text] [Related]
5. Enhanced risk of thromboembolic disease in hypertension from platelet hyperfunction and decreased fibrinolytic activity: has antihypertensive therapy any influence?
Winther K; Gleerup G; Hedner T
J Cardiovasc Pharmacol; 1992; 19 Suppl 3():S21-4. PubMed ID: 1376829
[TBL] [Abstract][Full Text] [Related]
6. Platelet function and fibrinolytic activity in hypertension: differential effects of calcium antagonists and beta-adrenergic receptor blockers.
Winther K; Gleerup G; Hedner T
J Cardiovasc Pharmacol; 1991; 18 Suppl 9():S41-4. PubMed ID: 1725542
[TBL] [Abstract][Full Text] [Related]
7. Impact of the therapy by renin-angiotensin system targeting antihypertensive agents perindopril versus telmisartan on prothrombotic state in essential hypertension.
Remková A; Kratochvíl'ová H; Durina J
J Hum Hypertens; 2008 May; 22(5):338-45. PubMed ID: 18305548
[TBL] [Abstract][Full Text] [Related]
8. Decreased fibrinolytic activity and increased platelet function in hypertension. Possible influence of calcium antagonism.
Gleerup G; Winther K
Am J Hypertens; 1991 Feb; 4(2 Pt 2):168S-171S. PubMed ID: 1827012
[TBL] [Abstract][Full Text] [Related]
9. Effect of antihypertensive agents on quality of life in the elderly.
Fogari R; Zoppi A
Drugs Aging; 2004; 21(6):377-93. PubMed ID: 15084140
[TBL] [Abstract][Full Text] [Related]
10. Renal protection and antihypertensive drugs: current status.
Salvetti A; Mattei P; Sudano I
Drugs; 1999 May; 57(5):665-93. PubMed ID: 10353294
[TBL] [Abstract][Full Text] [Related]
11. Plasma concentration of coagulation and fibrinolysis factors and platelet function in hypertension.
van Wersch JW; Rompelberg-Lahaye J; Lustermans FA
Eur J Clin Chem Clin Biochem; 1991 Jun; 29(6):375-9. PubMed ID: 1912085
[TBL] [Abstract][Full Text] [Related]
12. Effect of combined angiotensin-converting enzyme and aldosterone inhibition on plasma plasminogen activator inhibitor type 1 levels in chronic hypertensive patients.
Tiryaki O; Usalan C; Buyukhatipoglu H
Nephrology (Carlton); 2010 Mar; 15(2):211-5. PubMed ID: 20470281
[TBL] [Abstract][Full Text] [Related]
13. Dihydropyridine calcium antagonists increase fibrinolytic activity: a systematic review.
Vergouwen MD; Vermeulen M; de Haan RJ; Levi M; Roos YB
J Cereb Blood Flow Metab; 2007 Jul; 27(7):1293-308. PubMed ID: 17191079
[TBL] [Abstract][Full Text] [Related]
14. The role of angiotensin II type 1 receptor antagonists in elderly patients with hypertension.
Thomas GN; Chan P; Tomlinson B
Drugs Aging; 2006; 23(2):131-55. PubMed ID: 16536636
[TBL] [Abstract][Full Text] [Related]
15. Does antihypertensive therapy affect the natural protection against thrombosis?
Gleerup G; Hedner T; Hjørting Hansen E; Winther K
J Cardiovasc Pharmacol; 1991; 18 Suppl 3():S34-6. PubMed ID: 1720483
[TBL] [Abstract][Full Text] [Related]
16. Platelet (dys)function and plasma plasminogen levels in hemodialysis patients.
Salobir B; Sabovic M; Zupan IP; Ponikvar JB
Ther Apher Dial; 2008 Apr; 12(2):133-6. PubMed ID: 18387161
[TBL] [Abstract][Full Text] [Related]
17. Effect of organic nitrates on ex vivo platelet aggregation and fibrinolysis in man.
Wolfram G; Meyer U; Scheske U; Horn M; Drummer C; Spannagl M; Gerzer R
Eur J Med Res; 1996 Mar; 1(6):291-8. PubMed ID: 9367942
[TBL] [Abstract][Full Text] [Related]
18. Effects of astaxanthin on blood coagulation, fibrinolysis and platelet aggregation in hyperlipidemic rats.
Deng ZY; Shan WG; Wang SF; Hu MM; Chen Y
Pharm Biol; 2017 Dec; 55(1):663-672. PubMed ID: 27951728
[TBL] [Abstract][Full Text] [Related]
19. Effects of atenolol or losartan on fibrinolysis and von Willebrand factor in hypertensive patients with left ventricular hypertrophy.
Boman K; Boman JH; Andersson J; Olofsson M; Dahlöf B
Clin Appl Thromb Hemost; 2010 Apr; 16(2):146-52. PubMed ID: 19825910
[TBL] [Abstract][Full Text] [Related]
20. Platelet aggregation in hypertension and the effects of antihypertensive treatment.
Nyrop M; Zweifler AJ
J Hypertens; 1988 Apr; 6(4):263-9. PubMed ID: 2897988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
